| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.22 | 6e-06 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.22 | 7e-05 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 0.0002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |